One Genetic Change Shifted Two THC Tolerance Outcomes in Opposite Directions

Deleting beta-arrestin2 reduced tolerance to one THC effect while increasing tolerance to another in mice. The experiment shows why tolerance cannot always be described as a single change affecting every function equally.

A receptor-regulation experiment

Researchers compared male beta-arrestin2-knockout mice with wild-type littermates after acute and repeated THC. They measured pain-related withdrawal responses, immobility on a ring test and body temperature, alongside cannabinoid-receptor signaling in brain and spinal tissue.

The direction depended on the endpoint

Following repeated THC, knockout mice showed less tolerance to THC’s antinociceptive effect but greater tolerance to catalepsy. Acute catalepsy did not significantly differ by genotype. Both genotypes developed tolerance to hypothermia; the study could not calculate the dose-response potency estimates needed for the same numerical tolerance comparison on that outcome.

Why tissue location matters

Receptor adaptation differed across nervous-system regions. Removing a protein involved in receptor regulation did not prevent every form of desensitization. Some regions instead showed increased adaptation, consistent with overlapping regulatory pathways. Receptor binding, signaling and observable behavior therefore should not be treated as identical measurements.

The translational limit

These findings concern genetically modified mice and experimental THC dosing, not a genetic test that predicts a particular person’s driving or treatment response. No clinical benefit from manipulating beta-arrestin2 was established. For expert interpretation, the paper supports specifying the affected function and comparator; it does not support calling a cannabis user globally tolerant or globally unaffected.

Related analysis: evaluating cannabis tolerance claims.

Primary research

Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner. Biological psychiatry (2012). DOI: 10.1016/j.biopsych.2011.11.027.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Five-Puff Cannabis Challenge Did Not Guarantee Identical Oral-Fluid THC Exposure

Oral-fluid cannabinoid concentrations after a five-puff smoking challenge varied with preceding oral THC treatment. Standardizing puff count did not demonstrate identical smoke deposition or absorbed dose. A controlled but complex exposure history Eleven frequent smokers completed oral THC medication periods with a smoking challenge on the fifth day. Daily oral…

Spread the love

Read Article: A Five-Puff Cannabis Challenge Did Not Guarantee Identical Oral-Fluid THC Exposure

A Later Oral-Fluid THC Median Did Not Establish a Rebound in the Same Person

An oral-fluid cannabis study reported a slightly higher median THC concentration in a late time bin than in an earlier bin. The sampling design helps explain why that does not demonstrate a new rise within an individual. Repeated smoking with scheduled collections Eleven frequent cannabis smokers lived on a closed…

Spread the love

Read Article: A Later Oral-Fluid THC Median Did Not Establish a Rebound in the Same Person

Similar Temperature Tolerance Did Not Make THC and JWH Cannabinoids Interchangeable

THC and two synthetic cannabinoids all produced tolerance to hypothermia in mice, but that shared outcome did not make their pharmacology or risk equivalent. Other effects and regional adaptations differed. A comparison of different agonists Researchers compared THC with JWH-018 and JWH-073 using telemetry and laboratory receptor assays. The acute…

Spread the love

Read Article: Similar Temperature Tolerance Did Not Make THC and JWH Cannabinoids Interchangeable

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us